Results 151 to 160 of about 5,718,659 (207)

Immediate versus delayed short-course ruxolitinib for acute GVHD prophylaxis after myeloablative allogeneic hematopoietic stem cell transplantation. [PDF]

Front Immunol
Hua H, Wen S, Wang Y, Niu Z, Song Z, Zhou Z, Sun L, Xu Z, Yuan J, Wang Z, Li H, Zhang X, Wang F.   +12 more
europepmc   +1 more source

Long enduring response on teclistamab in a patient with myeloma relapse after allogeneic hematopoietic stem cell transplantation - a case report. [PDF]

Ann Hematol
Ebner P, Fauser J, Hetzenauer G, Köck S, Willenbacher W, Rossetti LM, Buchwald TA, Rasche L, Gunsilius E, Nachbaur D, Wolf D, Steiner N.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Allogeneic Hematopoietic Stem Cell Transplantation

Therapeutic Apheresis and Dialysis, 2003
Abstract: More than 30 years have passed since the first clinical application of allogeneic bone marrow transplantation to treat hematological diseases. In recent years, the availability of peripheral blood and cord blood as additional sources of stem cells other than bone marrow has expanded the applicability of hematopoietic stem cell transplantation.
Shunro, Kai, Hiroshi, Hara
openaire   +2 more sources

Nonablative allogeneic hematopoietic stem cell transplantation

Current Opinion in Oncology, 2001
During the past few years there has been an explosion of knowledge in nonablative allogeneic stem cell transplantation. This approach to transplantation relies more on the creation of "immunologic space" for engraftment rather than the more traditional approach of creating "physical space" by the application of either intensive radiation or chemical ...
R D, Dansey, R D, Baynes
openaire   +2 more sources

Allogeneic Hematopoietic Stem Cell Transplantation for Lymphoma

Clinical Lymphoma, 2004
For patients with relapsed or refractory Hodgkin's or non-Hodgkin's lymphomas, allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option when autologous HSCT fails to achieve durable remission or is deemed inappropriate. Allogeneic HSCT can result in long-term survival even in patients with refractory lymphomas.
Robert M, Dean, Michael R, Bishop
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation in the elderly

Critical Reviews in Oncology/Hematology, 2007
The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age limit that was set up by the transplant centers as an eligibility parameter. Analysis of the literature data showed that NST regimens are
Michael Y, Shapira, P, Tsirigotis, I B, Resnick, R, Or, A, Abdul-Hai, S, Slavin   +5 more
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

Current Opinion in Hematology, 2006
This review summarizes the current status and new developments in allogeneic hemopoietic stem cell transplantation strategies for patients with myelofibrosis with myeloid metaplasia, focusing on novel concepts of allogeneic transplantation with reduced-intensity conditioning.No substantial progress has been made in the conventional management of ...
Giovanni, Barosi, Andrea, Bacigalupo
openaire   +2 more sources

Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation

Annual Review of Immunology, 2007
Allogeneic hematopoietic stem cell transplantation (HSCT) has evolved into an effective adoptive cellular immunotherapy for the treatment of a number of cancers. The immunobiology of allogeneic HSCT is unique in transplantation in that it involves potential immune recognition and attack between both donor and host.
Lisbeth A, Welniak, Bruce R, Blazar, William J, Murphy   +2 more
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

Blood, 2003
Abstract Fifty-six patients, 10 to 66 years of age, with idiopathic myelofibrosis (IMF) or end-stage polycythemia vera or essential thrombocythemia received allogeneic hematopoietic cell transplants from related (n = 36) or unrelated (n = 20) donors.
H Joachim, Deeg, Theodore A, Gooley, Mary E D, Flowers, George E, Sale, John T, Slattery, Claudio, Anasetti, Thomas R, Chauncey, Kristine, Doney, George E, Georges, Hans-Peter, Kiem, Paul J, Martin, Effie W, Petersdorf, Jerald, Radich, Jean E, Sanders, Brenda M, Sandmaier, E Houston, Warren, Robert P, Witherspoon, Rainer, Storb, Frederick R, Appelbaum   +18 more
openaire   +2 more sources

Complications of Allogeneic Hematopoietic Stem Cell Transplantation

Cancer Investigation, 2014
Infection, graft-versus-host disease (GVHD), and to a lesser extent sinusoidal obstructive syndrome (SOS) represent the major causes of morbidity and mortality in patients undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). During the last decade, progress in prevention and treatment of these complications led to improvement in the ...
El-Amm, Joelle, Arnaout, Karim, Patel, Nihar, Jain, Maneesh, Amro, Farah, Tabbara, Imad A.   +5 more
openaire   +3 more sources